• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    A process for the preparation of 1,2,3-thiadiazol-5-yl ureas of the general formula <IMAGE> I in which a 1,2,3-thiadiazol-5-carbohydroxam acid derivative of the formula <IMAGE> II is dissolved in an inert organic solvent with an acid halide of the formula R4-X III to form an acylated derivative which then reacts with an amine of the formula <IMAGE> V to form the desired product.
    公开号:SU927114A3
    申请号:SU792842379
    申请日:1979-11-02
    公开日:1982-05-07
    发明作者:Крюгер Ханс-Рудольф
    申请人:Шеринг Аг(Фирма)；
    IPC主号:
    专利说明:

    I
    This invention relates to a process for the preparation of 1,2,3-thiadiazole-5-urea derivatives of the general formula Nn.
    N C-NH-CO-N, (D) 5

     ST1
    where R is hydrogen, lower alkyl; R is lower alkyl, cycloalkyl
    C5 C6, single or doubly substituted by lower alkyl o and / or halogen, and / or alkoxy, and / or trifluoromethyl, and / or nitro group, phenyl, substituted by lower alkyl or pyridyl halogen, 15 substituted by lower alkyl bromine pyrimidyl, RR together with the adjacent nitrogen atom form morpholino-piperidinoyl or pyrrolidino group, which are used as plant protection products. A method of producing 1,2,3 thiadiazol-5-yl-urea derivatives of the general formula 1 is known, namely, 25
    that 5-amino-1,2,3 thiadiazole is reacted with the corresponding isocyanates 1.
    The disadvantage of this method is the use of 5 am-1-2,3-thiadiazole, which is obtained in several stages, and its use is not entirely safe.
    The aim of the invention is to simplify the process technology.
    The goal is achieved by the method of obtaining derivatives of 1,2,3-thiadiazole-5IL-urea of general formula I, by the interaction of 1,2,3-thiadiazole-5-carbohydroxamic acid
    formulas
    N-CH O II II And (,, j
    C-C-NHOH
    N
    S
    with a solution of p-chloride toluenesulfonic acid in an organic solvent in the presence of an acid binding agent and with an amine of the general formula
    xv
    tl)
    HN
    In 3, where R and RZ: have the indicated meanings. Preferably the process is carried out at a temperature of from -20 ° to 100 ° C, preferably from O to 50 ° C. 1,2,3 Thiadiazole 5 carbohydroxamic acid of formula 1J can be obtained by the following methods already known: a) by reacting 1,2,3-thiadiazole-3-carboxylic acid ester with hydroxylamine in the presence of non-organic bases, such as hydroxide oxides, or carbonates and alcohols of comrades of alkaline and alkaline earth metals dissolved in polar organic solvents: b) 1,2,3-thiadiazole-5-carboxylic acid halide is reacted with hydroxylamine dissolved in an inert solvent, in the presence of. acid binding redstv. The proposed method is characterized by readily available starting materials and makes it possible to obtain the desired products in a technically simple and safe manner. In this case, a great technical advantage is that of the reaction. the mixture does not need to separate either the acylated carbohydroxamic acid derivative, or the 1,2,3 thiadiazol-5-yl-isocyanate formed during the Lossen rearrangement. In a one-step process, one can repeatedly convert a carbohydroxamic acid derivative of general formula II with an acid halide and an amine in the presence of an acid scavenger. The advantage is also that crude carbohydroxamic acid or its salts, as well as their crude solutions, can be used. The great advantage is that with this method of carrying out the reaction described in the experiment of the liquid part, the target product of the method is formed and no amide of acid used for the acylation of carbohydroxamic acid is formed at all. In addition, the reaction yields are extremely high. The conversion of 1,2,3 thiadiazole 5-carbohydroxamic acid of formula y, preferably in the form of a crude product, into 1,2,3-thiadiazole-5 or urea-formula 1, is based on the Lossen rearrangement through the formation of an acylated carbohydroxamic acid, which, as a rule , it is possible to use non-isolated, as well as through the stage of 1,2,3-thiadiazol-5-yl-isocyanate, which also, as a rule, is not isolated, and which is only formed in bulk and then proceeds to a subsequent reaction to the amine. The reaction takes place in the temperature range -20-100 ° C, preferably 0-50 ° C. The proposed method may, for example, proceed due to the fact that a crude solution of hydroxamic acid in a mixture with an equimolar amount of acid halide is mixed in an inert solvent medium with a mixture of equimolar amounts of amine and acid trap in an inert solvent; and convert the hydroxamic acid / acid halide mixture at the beginning with an acid scavenger, and only then with an amine; First, a mixture of hydroxamic acid / acid trap is converted with an acid halide and then only with an amine, or k. mixtures of hydroxamic acid, acid scavenger and amine add an acid halide. When using salts of hydroxamic acid, the use of an acid scavenger is rejected. As solvent inert to the reagents or suspending agents, the following should be mentioned: aliphatic and aromatic hydrocarbons, such as K iclohexane, heptane, ligroin, benzene, chlorobenzene, toluene and xylene, ethers such as diethyl ether, dioxane, tetrahydrofuran and diisopropyl ether esters, such as acetic and malonic esters, ketones, such as acetone, methyl isobutyl ketone, isophorone and cyclohexanone, halogenated hydrocarbons, such as methylene chloride, chloroform and carbon tetrachloride, amides, carb new acid, such as dimethylformamide, sulfoxides such as dimethyl sulfoxide. Suitable acid acceptors are organic bases, for example, such as triethylamine, N, M-dimethylaniline and pyridine bases, inorganic bases, such as oxides, hydroxides and carbonates of alkali and alkaline earth metals. Liquid bases, such as pyridines, can be simultaneously used as a solvent. After completion of the reaction, the reaction mixture is treated in a known manner, for example, the inorganic salts are filtered off and then the solvent used is distilled off under normal or reduced pressure, precipitated with water or the desired reaction product is filtered out several times and then the inorganic salts are washed away with water. In this way, the pure form of 1,2,3 thiadiazol-5-yl-urea is obtained in a very good yield, without the use of subsequent purification methods. This eliminates the problem of separation, which occurs during the reaction of 5 amino-1,2, 3 thiadiazole with isocyanates in connection with the formation of urea as a by-product. Example 1. Preparation of 1-phenyl-3 (1,2,3 Thiadiazole-3- or 1) urea from 1,2,3-thiadiazole-5-carbohydroxamic acid. In a three-neck 500 ml round-bottomed flask with a stirrer, a thermometer and a drying tube, 1.5 g (0.1 mol) of 1,2,3-thiadiazole-5-carbohydroxamic acid are suspended in 200 ml of tetrahydrofuran and mixed with g (0, 1 mol) p-toluenesulfonyl chloride dissolved in 50 ml of tetrahydrofuran. A mixture of ml (0.2 mol) of triethylamine and 9 "1 ml (0.1 mol) of aniline in 50 ml of tetrahydrofuran is added dropwise to this solution for 10 minutes. The temperature in the flask is maintained in the range. A light yellow reaction mixture is formed. Stir for 1 hour at and for 1 hour at room temperature, while the temperature in the flask soon rises to 28 ° C. After standing overnight, the mixture is evaporated in vacuo at 0 ° C. The residue is mixed with 800 ml of ice water, after grinding for a short time almost white crystals are obtained.
    1- (4-Chlorophenyl) -3- (1,2, 3-thiadiazol-5 yl) -urea1
    1-Cyclohexyl-3- (1,2, 3-thiadiazol-5-yl) -urea2
    1- (3-Chlorophenyl) (1,2, 3-thiadiazol-5-yl) -urea3
    1 - (- Methylphenyl) -5 (112.3 thiadiazol-5 yl) urea4
    1- (3-Methylphenyl) -3- (1,2,3-thiadiazol-5 yl) -urea 5 1- (3, -Dichlorophenyl) -3 (1,2,3 thiadiazol-5 yl) -urea 6
    1-Methyl-3 (1) 2, 3-thiadiazol-5-yl) ureaJ
    1,1-DIMRTIL-3- (1.2, 3-thiadiazol-5-yl) -urea, which is sucked off, washed with water and dried in vacuum at room temperature to constant weight. Yield 14.9 g, which is 67.7% of theoretical. Melting point 208-210 ° C (with decomposition). Thin layer chromatography: solvent: ethyl acetate, Rf value 0.25. Example 2. Getting 1-phenyl 3 (1,2,) - urea from 1,2,3, adiazole-5-carbohydroxamic acid. In a three-neck 100 ml round-bottomed flask with a stirrer, a thermometer and a drying tube, 1.5 g (0.01 mol) of 1,2,3-thiadi-5-carbohydroxamic acid are suspended in 20 ml of tetrahydrofuran and then mixed with a mixture of 2.8 ml (0.02 mol) of triethylamine and 0.91 ml (0.01 mol) of aniline. A solution of 1.9 g (0.01 mol) of p-toluenesulfonic acid chloride in 5 ml of tetrahydrofuran is added dropwise to the mixture at 10 ° C for 10 minutes. The mixture is stirred at room temperature for 1 hour and at room temperature. The temperature inside the flask quickly rises to 27 ° C. The mixture is left to stand overnight and then evaporated in vacuo, the residue is mixed with 80 ml of ice water, the crystals are sucked off, washed with water and dried in vacuo at room temperature to constant weight. Yield 1.5 g, which is 68.1% of theoretical. Melting point 208-210 ° C (with decomposition). In a similar way, the following 1,2,3-thiadiazol-5-yl-urea was obtained, and the molar ratios between 1,2,3 Thiadiazole-5-carbohydroxamic acid (0.1 mol) (para-toluenesulfonic acid chloride (0.1 mol ), triethylamine (0.2 mol) and amine (0.1 mol). The names of the compounds in the table are given below.
    792711 48
    1- (, 2, 3 Thiadiazol-5-yl) -3 (3 trifluoromete 1lphenig) -urea9 1 - (- Nitrophenyl) -3 (, 3-thiadiazol-5-yl) -urea10 1- (2 -) (lorofenyl -3- (1,2, 3 thiadiazol-5 yl) -urea11 1- (2-Methylphenyl) -3- (1,2, 3 thiadiazol-5 yl) -urea12 1- (2-Nitrophenyl) -3- (1,2, 3-thiadiazol-5-yl) -urea13 1- (3-Nitrophenyl) -3- (1, 2, 3-thiadiazol-5-yl) -urea1 / 4 1-Methyl-1-phenyl- 3- (1,2,3 Thiadiazol-5-yl) -mevine 15 1-E. Methyl 1-phenyl-3- (1, 2, 3-thiadiazol-5-yl) -urea 1b 1-Phenyl-1-propyl -3- (1,2, 3-thiadiazal-5-yl) -urea17 1-1 util-1-phenyl-3- (1, 2,3-thiadiazap-5-yl) -urea18 1-Methyl-1- (2-methylphenyl) -3- (1,2, ZTiadiazol-5-yl) -urea19 1,1-Diethyl-3- (1,2,3-thiadiazol-5 yl) -m ochevina .20 5- (1-Pyrrolidylcarbonylamino) -1,2, Ztiadiaeol21 1- (2-Methoxyphenyl) -3- (1,2, 3-thiadiaeol-5-yl) -urea8ina22 5- (1-Piperidylcarbonylamino) -1 , 2,3, -thiadiaeol / 23 5- (1-Morpholylcarbonylamino) -1, 2, 3-Thiadiazole2 1- (2-Chloro-6-methylphenyl) -3- (1,2, З-thiadiaeol-Zyl) - urea 25 1- (2-Isopropylphenyl) -3- (1,2, 3-thiadiazol-5-yl) -urea26 1-Cyclopropyl-3- (1,2,3-thiadiazol-5yl) -urea27 1-Propyl- 3- (1,2, 3-thiadiazol-5-yl) -urea28 1-Butyl-3- (1,2,3-thiadiazol-5-yl) -urea29 1-Cyclohexyl-1-propyl 3- (1, 2, 3-thiadiazol-5-yl) -30-urea
    1- (1,2, 3-Thiadiazol-5-yl) -3 (2-trifluoromethylphenyl) - urea 31 1 -Cyclohexyl-1-isopropyl-3- (1,2, 3-thiadiazol-5-yl) urea, 32 1- (5-Chloro-2-pyridyl) -3- (1,2, 3-thiadiazol-5-yl) -urea33 1 - (- Methyl-2-pyridyl) -3- (1,2, 3- thiadiazol-5-yl) -urea3 1 (-methyl-2-pyrimidyl) 2- (1,2, 3-thiadiazol-5-yl) -urea35 1 - (- Pyridyl) -3- (1,2,3- thiadiazol-5-yl) -urea36 1- (3-Pyridyl) -3- (1, 2, 3-thiadiazol-5-yl) -urea3 7 1- (2-Pyrimidyl) -3- (1,2,3 Thiadiazol-5-yl) -move signal 33 1- (3-Methyl-2-pyridyl) -3 (1,2, 3-thiadiazol-5-yl) -urea39 1- (5-Methyl-2-pyridyl) -3- (1,2, 3-thiadiazol-5-yl) -urea40 1- (6-Methyl-2-pyridyl) -3- (1,2,3-thiadiazole 5-yl) -urea 1- (2-Pyridi l) -3- (1,2, 3-thiadiazol-5-yl) -ureaC2
    ft
    s
    So
    .
    -
     r
    §one
    rs.
    S
    Csl
    MF
    ii
    and q
    -3CvJ
    O co vo
    -T
    r
    - vO -
    (P
    1L 1L
    r
    00
    vO
    T
    rf M
    K v
    CHO 00
    -Lel cr
    sgch - m
    h
    go
    GL
    go
    go
    01-
    vO
    go oo
    :
    go -3CN
    权利要求:
    Claims (1)
    [1]
    -A21 Claim 1. Method for producing 1,2,3-thiadiazol-5 or urea-compounds of the general formula I N-CH l - v: n II II c JN C-NH-CO-N N "-g. SR hydrogen, lower alkyl, R lower alkyl, cycloalkyl Cs-Cb, one or two times substituted by lower alkyl and / or halogen, and / or alkoxy, and / or trifluoromethyl, and / or nitro, phenyl, substituted by lower alkyl or halogen, pyridyl, substituted by lower alkyl pyridyl, R + R together with the adjacent nitrogen atom forms morpholino, piperidino or pyrrolidino group from 1,2, Ztiadiazole derivatives, which, in order to simplify the process technology, as a derivative 1,2 , 3 thiadiazole use 1,2,3 thiad22 azole-5 car6hydroxamic acid for CH o and P II mules; N C-C-TYANON which is reacted with p-toluenesulfonic acid chloride solution with an organic solvent in the presence of an acid binding agent and with an amine of the general formula H-ieC 9 where R and R have the indicated values. 2, the method according to claim 1, wherein the process is carried out at a temperature of from -20 to 100 ° C; preferably from 0 to 50 ° C. Sources of information taken into account in the examination 1. Application of Germany No. 22663, class, 07 d SI / S, published, 1975 (prototype).
    类似技术:
    公开号 | 公开日 | 专利标题
    RU1836362C|1993-08-23|A method for obtaining 5-[2-|ethenyl] -5,6-dihydro-1,3,4 -thiadiazine-2- |-ones
    SU927114A3|1982-05-07|Process for producing derivatives of 1,2,3-thiadiazol-5-ylurea
    JP3850838B2|2006-11-29|Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
    SU403189A1|METHOD OF OBTAINING 1,3,4-TIADYLSOLYL-5-UREA
    PL174526B1|1998-08-31|Novel compounds - derivatives of carbazolone
    US3960856A|1976-06-01|Process for the preparation of 4-hydroxy-3-|-2-methyl-2H-1,2-benzothiazine 1,1-dioxide
    US4175184A|1979-11-20|Manufacture of 2,1,3-thiadiazin-4-one-2,2-dioxide derivatives
    EP0041359A1|1981-12-09|Process for the preparation of heterocyclylalkyl guanidines; intermediates and their preparation
    Rykowski et al.1988|Reactions of organic anions, 139. Vicarious nucleophilic substitution of hydrogen in 1, 2, 4‐triazine derivatives
    ANTHONI et al.1968|IV. Dimerization of/V-Isothioeyanatodimethylamine
    FI66605C|1984-11-12|FRAMSTAELLNINGSFOERFARANDE FOER 5-MERKAPTO-1,2,3-TRIAZOLER
    SU921466A3|1982-04-15|Method of producing 1,2,3-thiadiazol-5-il-ureas
    US3655665A|1972-04-11|Process for the production of 5-cyano-uracils
    US3534057A|1970-10-13|Halogenation process for the production of certain oxadiazolidines and thiadiazolidines
    US4581175A|1986-04-08|N&#39;-acylhydrazine-N-thiocarboxylic acid O-carbamoylmethyl esters
    RU2032679C1|1995-04-10|Derivatives of benzathiazines
    US5710319A|1998-01-20|Process for the preparation of substituted quinazoline-2,4-diones
    Pilgram1982|5‐Substituted‐3‐| phenyl‐1, 3, 4‐oxadiazolin‐2 |‐ones. Synthesis and reactions with nucleophilic reagents
    JPH05202059A|1993-08-10|New tricyclic hetero cycle compound and its production
    US4375435A|1983-03-01|3-,4-Dihydroimidazo |-1,3-pyrimidines and 4,5-dihydroimidazo |-1,3-diazepines
    KR830000271B1|1983-02-26|Method for preparing 1,2,3-thiadiazol-5-yl urea
    US4287343A|1981-09-01|Preparation of N-cyanoimidate herbicide intermediates
    US5780628A|1998-07-14|Process for producing dioxoquinazolines
    JPH06228149A|1994-08-16|Novel pentacyclic heterocyclic compound, production intermediate and their production
    US4443375A|1984-04-17|Tetrahydroimidazo|-1,3-diazocine intermediates for production of guanidines
    同族专利:
    公开号 | 公开日
    HU183104B|1984-04-28|
    ES485650A1|1980-05-16|
    AU528407B2|1983-04-28|
    BG35046A3|1984-01-16|
    IL58572A|1983-10-31|
    BR7907117A|1980-09-09|
    US4358596A|1982-11-09|
    SE7909017L|1980-05-04|
    LU81834A1|1980-01-25|
    IE792112L|1980-05-03|
    GR74077B|1984-06-06|
    RO78090A|1982-02-01|
    FR2440947B1|1983-09-16|
    ZA795893B|1980-12-31|
    MX5790E|1984-07-11|
    PT70398A|1979-11-01|
    PL219405A1|1980-12-01|
    PL130308B1|1984-07-31|
    ATA703179A|1983-07-15|
    DE2848330A1|1980-05-14|
    GB2039889A|1980-08-20|
    BE879830A|1980-05-05|
    IE49107B1|1985-08-07|
    FR2440947A1|1980-06-06|
    AR224253A1|1981-11-13|
    NL7907673A|1980-05-07|
    DD147109A5|1981-03-18|
    IL58572D0|1980-01-31|
    JPS5826913B2|1983-06-06|
    CH641793A5|1984-03-15|
    FI793367A|1980-05-04|
    IT1165334B|1987-04-22|
    DK459579A|1980-05-04|
    IT7926898D0|1979-10-30|
    PH15680A|1983-03-11|
    YU251479A|1983-04-30|
    EG14043A|1982-09-30|
    AT373885B|1984-02-27|
    NZ191933A|1981-03-16|
    TR20548A|1981-10-15|
    CA1131639A|1982-09-14|
    AU5248979A|1980-05-08|
    CS214675B2|1982-05-28|
    JPS5566571A|1980-05-20|
    GB2039889B|1983-04-13|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    DD103124A5|1972-03-23|1974-01-12|
    DE2636994C2|1976-08-13|1984-10-18|Schering AG, 1000 Berlin und 4709 Bergkamen|Process for the preparation of 5-amino-1,2,3-thiadiazole|DE2920939A1|1979-05-21|1980-11-27|Schering Ag|METHOD FOR PRODUCING 5-MERCAPTO-1,2,3-TRIAZOLES|
    DE3139506A1|1981-10-01|1983-04-21|Schering Ag, 1000 Berlin Und 4619 Bergkamen|1,2,3-THIADIAZOL-5-YL-UREA DERIVATIVES, METHOD FOR THE PRODUCTION OF THESE COMPOUNDS AND THEIR CONTAINING AGENTS WITH GROWTH REGULATIVE AND DEFOLIATING EFFECT|
    DE3139505A1|1981-10-01|1983-04-21|Schering Ag, 1000 Berlin Und 4619 Bergkamen|1,2,3, -THIADIAZOL-5-YL-UREA DERIVATIVES, METHOD FOR PRODUCING THESE COMPOUNDS AND THEIR CONTAINING AGENTS WITH GROWTH REGULATIVE AND DEFOLIATING EFFECT|
    DE3319008A1|1983-05-20|1984-11-22|Schering AG, 1000 Berlin und 4709 Bergkamen|1,2,3-THIADIAZOL-3-IN-5-YLIDEN-UREA DERIVATIVES, METHOD FOR THE PRODUCTION OF THESE COMPOUNDS AND THEIR CONTAINING AGENTS WITH GROWTH REGULATIVE AND DEBELLING EFFECT|
    US6166054A|1995-03-31|2000-12-26|Nihon Nohyaku Co., Ltd.|Agricultural and horticultural disease controller and a method for controlling the diseases|
    ES2384160T3|1999-01-13|2012-07-02|Bayer Healthcare Llc|Diphenyl ureas substituted with omega-carboxy aryl as kinase inhibitors p38|
    US8124630B2|1999-01-13|2012-02-28|Bayer Healthcare Llc|ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors|
    WO2003068228A1|2002-02-11|2003-08-21|Bayer Pharmaceuticals Corporation|Aryl ureas with angiogenesis inhibiting activity|
    US7557129B2|2003-02-28|2009-07-07|Bayer Healthcare Llc|Cyanopyridine derivatives useful in the treatment of cancer and other disorders|
    EP1626714B1|2003-05-20|2007-07-04|Bayer Pharmaceuticals Corporation|Diaryl ureas for diseases mediated by pdgfr|
    JP4777887B2|2003-07-23|2011-09-21|バイエル、ファーマシューテイカルズ、コーポレイション|Fluoro-substituted omegacarboxyaryl diphenylureas for the treatment and prevention of diseases and conditions|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    DE19782848330|DE2848330A1|1978-11-03|1978-11-03|METHOD FOR PRODUCING 1,2,3-THIADIAZOL-5-YL UREA|
    [返回顶部]